Skip to main content

Advertisement

Log in

Can we predict mediastinal lymph nodes metastasis in esophagogastric junction cancer? Results of a systematic review and meta-analysis

  • Review Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Purpose

The aim of this systematic review and meta-analysis was to define clinical indicator that predicts mediastinal lymph nodes metastasis (MLNM) in patients with Esophagogastric junction cancer (EGJC) to select patient population requiring esophagectomy.

Methods

A systematic and electronic search of several electronic databases was performed up to August 2020. Studies containing information on risk factors for MLNM in patients diagnosed with EJGC and who underwent curative surgery were included.

Results

Two predictors, including undifferentiated type (OR = 1.82, 95% CI = 1.07–3.10, p = 0.03) and esophageal invasion length (EIL) (OR = 10.95, 95% CI = 6.37–18.82, p < 0.00001) were identified as significant predictors for the risk of MLNM.

Conclusion

Knowledge of the associations of these clinicopathological features with MLNM can be useful in determining operative strategy for EGJC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Han WH, Eom BW, Yoon HM, Reim D, Kim Y-W, Kim MS, et al. The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study. BMC Cancer. 2019;19(1):719.

    Article  Google Scholar 

  2. Greally M, Agarwal R, Ilson DH. Optimal management of gastroesophageal junction cancer. Cancer. 2019;125(12):1990–2001.

    Article  Google Scholar 

  3. Shiraishi O, Yasuda T, Kato H, Iwama M, Hiraki Y, Yasuda A, et al. Risk factors and prognostic impact of mediastinal lymph node metastases in patients with esophagogastric junction cancer. Ann Surg Oncol. 2020;27(11):4433–40.

    Article  Google Scholar 

  4. Kurokawa Y, Hiki N, Yoshikawa T, Kishi K, Ito Y, Ohi M, et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery. 2015;157(3):551–5.

    Article  Google Scholar 

  5. Peng J, Wang W-P, Yuan Y, Hu Y, Wang Y, Chen L-Q. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction adenocarcinoma. Ann Thorac Surg. 2015;100(1):263–9.

    Article  Google Scholar 

  6. Sakaki A, Kanamori J, Ishiyama K, Kurita D, Oguma J, Daiko H. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors. Langenbecks Arch Surg. 2020;405:509–19.

    Article  Google Scholar 

  7. Fang W-L, Wu C-W, Chen J-H, Lo S-S, Hsieh M-C, Shen K-H, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol. 2009;16(12):3237–44.

    Article  Google Scholar 

  8. Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19(2):677–83.

    Article  Google Scholar 

  9. Koyanagi K, Kato F, Kanamori J, Daiko H, Ozawa S, Tachimori Y. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: a retrospective single-institution study. Ann Gastroenterological Surg. 2018;2(3):187–96.

    Article  Google Scholar 

  10. Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M, et al. Clinicopathological characteristics and prognostic factors of patients with siewert type II esophagogastric junction carcinoma: a retrospective multicenter study. World J Surg. 2016;40(7):1672–9.

    Article  Google Scholar 

  11. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, et al. Mediastinal nodal involvement after neoadjuvant chemoradiation for Siewert II/III adenocarcinoma. Ann Thorac Surg. 2019;108(3):845–51.

    Article  Google Scholar 

  12. Sugita S, Kuwata T, Tokunaga M, Kaito A, Watanabe M, Tonouchi A, et al. Clinical significance of lymphatic invasion in the esophageal region in patients with adenocarcinoma of the esophagogastric junction. J Surg Oncol. 2020;122(3):433–41.

    Article  Google Scholar 

  13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34.

    Article  Google Scholar 

  14. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011.

    Google Scholar 

  15. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

    Article  Google Scholar 

  16. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–34.

    Article  CAS  Google Scholar 

  17. Ren G, Chen Y-W, Cai R, Zhang W-J, Wu X-R, Jin Y-N. Lymph node metastasis in gastric cardiac adenocarcinoma in male patients. World J Gastroenterol. 2013;19(37):6245.

    Article  Google Scholar 

  18. Zheng Z, Yin J, Wu H-W, Li J, Cai J, Qin S-Q, et al. Explored risk factors for lymph node metastasis with Siewert II/III adenocarcinoma of the gastroesophageal junction. Anticancer Res. 2017;37(8):4605–10.

    PubMed  Google Scholar 

  19. Zheng Z, Shang Y, Xu R, Zhang H, Yin J, Zhang J, et al. Risk factors and prognosis in patients with adenocarcinoma of esophagogastric junction with lymph node metastasis of Siewert II/III. Int J Clin Exp Pathol. 2020;13(5):1262.

    PubMed  PubMed Central  Google Scholar 

  20. Batool S, Khan M, Akbar SA, Ashraf I. Risk factors and patterns of recurrence after curative resection in gastroesophageal junction adenocarcinoma. Pak J Med Sci. 2019;35(5):1276.

    PubMed  PubMed Central  Google Scholar 

  21. Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, et al. Thoracic lymph node involvement in adenocarcinoma of the esophagogastric junction and lower esophageal squamous cell carcinoma relative to the location of the proximal end of the tumor. Ann Surg Oncol. 2014;21(5):1596–601.

    Article  Google Scholar 

  22. Chen L, Wang YH, Cheng YQ, Du MZ, Shi J, Fan XS, et al. Risk factors of lymph node metastasis in 1620 early gastric carcinoma radical resections in Jiangsu Province in China: a multicenter clinicopathological study. J Dig Dis. 2017;18(10):556–65.

    Article  Google Scholar 

  23. Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg. 2015;99(6):1879–86.

    Article  Google Scholar 

  24. Jiang B, Zhou L, Lu J, Wang Y, Guo J. Predictors of lymph node metastasis and residual tumor in early gastric cancer patients after noncurative endoscopic resection: a systematic review and meta-analysis. Ther Adv Gastroenterol. 2020;13:1756284820935033.

    Article  Google Scholar 

  25. Miyahara K, Hatta W, Nakagawa M, Oyama T, Kawata N, Takahashi A, et al. The role of an undifferentiated component in submucosal invasion and submucosal invasion depth after endoscopic submucosal dissection for early gastric cancer. Digestion. 2018;98(3):161–8.

    Article  CAS  Google Scholar 

  26. Kurokawa Y, Takeuchi H, Doki Y, Mine S, Terashima M, Yasuda T, et al. Mapping of lymph node metastasis from oesophagogastric junction tumours: a prospective nationwide multi-centre study. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003499.

    Article  PubMed  Google Scholar 

  27. Yamashita H, Seto Y, Sano T, Makuuchi H, Ando N, Sasako M. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma. Gastric Cancer. 2017;20(1):69–83.

    Article  CAS  Google Scholar 

  28. Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42(4):351–8.

    Article  Google Scholar 

Download references

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed Maatouk.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

No ethical approval required as this research project is a systematic review of previous studies.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maatouk, M., Ben Safta, Y., Kbir, G.H. et al. Can we predict mediastinal lymph nodes metastasis in esophagogastric junction cancer? Results of a systematic review and meta-analysis. Gen Thorac Cardiovasc Surg 69, 1165–1173 (2021). https://doi.org/10.1007/s11748-021-01665-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-021-01665-7

Keywords

Navigation